Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa D Conrad

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Open Forum Infectious Diseases|May 9, 2017
Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine Exert Inverse Selective Pressure on <i>Plasmodium Falciparum</i> Drug Sensitivity-Associated Haplotypes in UgandaAimee R Taylor, Jennifer A Flegg, Chris C Holmes, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2018
Changing Molecular Markers of Antimalarial Drug Sensitivity across UgandaVictor Asua, Joanna Vinden, Melissa D Conrad, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2017
Changing Antimalarial Drug Sensitivities in UgandaStephanie A Rasmussen, Frida G Ceja, Melissa D Conrad, et al.
Malaria Journal|March 18, 2014
Validation of the ligase detection reaction fluorescent microsphere assay for the detection of Plasmodium falciparum resistance mediating polymorphisms in UgandaSheila Nankoberanyi, George W Mbogo, Norbert P LeClair, et al.
Antimicrobial Agents and Chemotherapy|October 6, 2020
Associations between Malaria-Preventive Regimens and Plasmodium falciparum Drug Resistance-Mediating Polymorphisms in Ugandan Pregnant WomenPatience Nayebare, Victor Asua, Melissa D Conrad, et al.
Antimicrobial Agents and Chemotherapy|March 10, 2022
Impact of Short-Term Storage on <i>Ex Vivo</i> Antimalarial Susceptibilities of Fresh Ugandan Plasmodium falciparum IsolatesMartin Okitwi, Stephen Orena, Katairo Thomas, et al.
The Lancet. Infectious Diseases|March 29, 2024
The emergence of artemisinin partial resistance in Africa: how do we respond?Philip J Rosenthal, Victor Asua, Jeffrey A Bailey, et al.
Malaria Journal|January 2, 2021
Deletions of pfhrp2 and pfhrp3 genes were uncommon in rapid diagnostic test-negative Plasmodium falciparum isolates from UgandaSam L Nsobya, Andrew Walakira, Elizabeth Namirembe, et al.
The Lancet. Microbe|March 20, 2025
Selection of Plasmodium falciparum kelch13 mutations in Uganda in comparison with southeast Asia: a modelling studyCecile P G Meier-Scherling, Oliver J Watson, Victor Asua, et al.
The Journal of Infectious Diseases|March 11, 2014
Comparative impacts over 5 years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan childrenMelissa D Conrad, Norbert LeClair, Emmanuel Arinaitwe, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Open Forum Infectious Diseases|May 9, 2017
Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine Exert Inverse Selective Pressure on <i>Plasmodium Falciparum</i> Drug Sensitivity-Associated Haplotypes in UgandaAimee R Taylor, Jennifer A Flegg, Chris C Holmes, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2018
Changing Molecular Markers of Antimalarial Drug Sensitivity across UgandaVictor Asua, Joanna Vinden, Melissa D Conrad, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2017
Changing Antimalarial Drug Sensitivities in UgandaStephanie A Rasmussen, Frida G Ceja, Melissa D Conrad, et al.
Malaria Journal|March 18, 2014
Validation of the ligase detection reaction fluorescent microsphere assay for the detection of Plasmodium falciparum resistance mediating polymorphisms in UgandaSheila Nankoberanyi, George W Mbogo, Norbert P LeClair, et al.
Antimicrobial Agents and Chemotherapy|October 6, 2020
Associations between Malaria-Preventive Regimens and Plasmodium falciparum Drug Resistance-Mediating Polymorphisms in Ugandan Pregnant WomenPatience Nayebare, Victor Asua, Melissa D Conrad, et al.
Antimicrobial Agents and Chemotherapy|March 10, 2022
Impact of Short-Term Storage on <i>Ex Vivo</i> Antimalarial Susceptibilities of Fresh Ugandan Plasmodium falciparum IsolatesMartin Okitwi, Stephen Orena, Katairo Thomas, et al.
The Lancet. Infectious Diseases|March 29, 2024
The emergence of artemisinin partial resistance in Africa: how do we respond?Philip J Rosenthal, Victor Asua, Jeffrey A Bailey, et al.
Malaria Journal|January 2, 2021
Deletions of pfhrp2 and pfhrp3 genes were uncommon in rapid diagnostic test-negative Plasmodium falciparum isolates from UgandaSam L Nsobya, Andrew Walakira, Elizabeth Namirembe, et al.
The Lancet. Microbe|March 20, 2025
Selection of Plasmodium falciparum kelch13 mutations in Uganda in comparison with southeast Asia: a modelling studyCecile P G Meier-Scherling, Oliver J Watson, Victor Asua, et al.
The Journal of Infectious Diseases|March 11, 2014
Comparative impacts over 5 years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan childrenMelissa D Conrad, Norbert LeClair, Emmanuel Arinaitwe, et al.
Pageof 7